BioRestorative Therapies, Inc.
BRTX
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M |
| Total Depreciation and Amortization | 52.70K | 51.80K | 50.40K | 48.30K | 47.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -179.60K | 2.54M | -850.70K | -879.20K | 1.92M |
| Change in Net Operating Assets | 89.30K | -31.20K | 88.60K | 222.80K | 193.00K |
| Cash from Operations | -2.69M | -2.78M | -2.35M | -1.70M | -1.87M |
| Capital Expenditure | 0.00 | -36.40K | -12.40K | -58.50K | -35.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.13M | 2.40M | 1.55M | 995.20K | 3.01M |
| Cash from Investing | 2.13M | 2.37M | 1.53M | 936.80K | 2.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39.20K | -33.60K | -- | -- | -- |
| Issuance of Common Stock | 927.30K | 1.08M | 0.00 | 595.40K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 42.40K | -126.30K | -595.40K | -12.80K |
| Cash from Financing | 888.10K | 1.09M | -126.30K | 0.00 | -12.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 326.50K | 680.90K | -941.60K | -762.80K | 1.10M |